Through this project, the aim is to screen 100,000 individuals, focusing on the following types of cancers: oral, breast, cervix, colorectal, and prostate
Karkinos Healthcare and Bayer are collaborating to scale up cancer screening in target communities in Mumbai and Puducherry, India. The collaboration combines Karkinos’ focus on early detection with Bayer’s vision of “Health for All” and aims to remedy cancer care disparities in target communities over the next two years. Through this project, the aim is to screen 100,000 individuals, focusing on the following types of cancers: oral, breast, cervix, colorectal, and prostate. The initiative also ensures a care continuum by working closely in partnership with the community and local institutions.
Dr Chitkala Kalidas, Global Head, Oncology Sustainability & Health Equity from Bayer said, “By harnessing Bayer’s extensive global healthcare capabilities and Karkinos Healthcare’s expertise in early cancer identification, we initiate a journey of profound change. Our collaborative endeavour, designed to redefine cancer screening, emerges as an innovative model for decentralised high-quality cancer care by enhancing health literacy and early detection to enable timely treatment. Through these efforts, we are building capacity at the grassroots level to strengthen health systems and deliver patient-centric cancer care in their community settings.”
Manoj Saxena, Managing Director, Bayer Pharma said “We continue to build momentum in our commitment towards ‘health for all’ globally, with India at the center of Bayer’s health sustainability initiatives, especially in the areas of oncology and women’s reproductive health. We are proud to partner with Karkinos Healthcare to improve cancer detection and care in India. Screening and timely detection are critical for maximising health outcomes in patients with cancer. With the availability of advanced screening technologies and solutions, early detection of different types of cancers is possible. Our collaboration with Karkinos Healthcare will increase access to latest screening technologies for those in need, making timely diagnosis a reality for all”.
Dr Moni Abraham Kuriakose, Co-Founder, Medical Director, & CEO Kerala Operations, Karkinos Healthcare, said, “Early detection is the cornerstone for conquering cancer, enabling more effective and less invasive treatments. Teaming up with Bayer, we’re starting a big effort to transform how we find cancer early in India. Our shared goal of making healthcare accessible fits perfectly with our mission towards accessible and affordable cancer care in the country. This project is like a guiding light, bringing together easy-to-reach healthcare, new ideas, and smart partnerships. Our focus is on making a real difference in fighting cancer and helping our communities. It’s not just about medicine – it’s about improving lives, giving people strength, and making a better future for everyone affected by cancer.”
This comprehensive cancer screening and early detection initiative will include inviting participants systematically, conducting screening tests based on individualised risk assessment, evaluating diagnostics, and referring positive cases to appropriate medical centers for treatment. Karkinos will utilise its existing network to amplify cancer awareness and screening across diverse community settings in these regions.